Evidence map›Paper›PMID 42707161›Full record

ArticleFrontiers in oncology2026

A pretreatment multiphasic CT-based decision-support model for differentiating pediatric hepatoblastoma from focal nodular hyperplasia.

Lizhu Cai, Yun Peng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lizhu CaiDepartment of Radiology, MOE Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yun PengDepartment of Radiology, MOE Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatoblastoma (HB) and focal nodular hyperplasia (FNH) require markedly different management strategies in children, but differentiation can be challenging when multiphasic computed tomography (CT) findings are atypical or overlapping. This study aimed to develop and temporally validate a pretreatment multiphasic CT-based fusion model combining deep learning (DL) predictions with quantitative enhancement features for pediatric HB-FNH differentiation and to evaluate the potential value of model assistance for junior-radiologist interpretation. Methods: This retrospective study included 612 children who underwent pretreatment multiphasic CT between January 2011 and September 2025, including 523 with HB and 89 with FNH. A chronological split on July 1, 2023 assigned 491 patients to model development and 121 patients to temporal testing. Three phase-specific DL models based on 2.5D ResNet-18 were trained using precontrast, arterial-phase, and portal venous-phase images, and their predicted probabilities were averaged to generate DL-3Phase. Quantitative enhancement features from standardized manual region-of-interest attenuation measurements were used to train a regularized logistic regression model, termed the quantitative enhancement feature (QEF) model. DL+QEF was prespecified as the unweighted average of the DL-3Phase and QEF model probabilities. Performance was assessed using the area under the receiver operating characteristic curve (AUC), diagnostic accuracy metrics, calibration, decision curve analysis, and comparison with radiologist interpretation. Results: In the temporal test cohort, DL+QEF achieved an AUC of 0.980, an accuracy of 94.2%, an HB sensitivity of 94.9%, and an FNH specificity of 92.9%. DL+QEF showed better discrimination than DL-3Phase and the best-performing single-phase DL model, and combined the high HB sensitivity of DL-3Phase with the high FNH specificity of the QEF model. In the pathology-confirmed test subset, the AUC was 0.972 and accuracy was 92.9%. Junior-radiologist accuracy was 88.4% during unaided reading and 95.0% during model-assisted reading (exact McNemar Conclusion: The pretreatment multiphasic CT-based DL+QEF model showed favorable diagnostic performance for pediatric HB-FNH differentiation and may serve as an adjunct to CT interpretation, with potential utility in reader-defined atypical or diagnostically uncertain cases.

Indexed as

deep learningfocal nodular hyperplasiahepatoblastomamultiphasic contrast-enhanced CTquantitative enhancement features

Identifiers

PMID42707161
PMCPMC13547000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.